Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Multicenter, Open-label, Expanded Access Study of KTE-X19 for the Treatment of Subjects with Relapsed/Refractory B-Cell Malignancies (ZUMA-18)

Lymphoma

Lymphoma
II
Oluwole, Olalekan
NCT04162756
VICCBMT19124

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: